MSTN and cancer: Indeed, several indications recommended the use of strategies aimed at antagonizing myostatin in order to enhance muscle anabolism and prevent muscle catabolism in cancer cachexia and to prolong life, even in the absence of direct effects on tumor growth [13, 16–19].